Humacyte, Inc. (HUMA)

Last Closing Price: 2.77 (2025-05-29)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Humacyte, Inc. (HUMA) had Net Income of $39.14M for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$0.52M
Net Income
$39.14M
$0.15M
$0.37M
$23.70M
$-23.18M
$62.32M
$39.14M
$39.14M
$39.14M
$39.14M
$39.14M
$39.14M
$-23.18M
$-21.35M
131.50M
131.76M
$0.28
$0.28
Balance Sheet Financials
$73.70M
$22.44M
$88.85M
$162.55M
$20.03M
$12.84M
$106.48M
$126.51M
$36.04M
$36.04M
$36.04M
155.12M
Cash Flow Statement Financials
$-28.60M
$-0.23M
$46.74M
$95.29M
$113.20M
$17.91M
$2.49M
--
--
Fundamental Metrics & Ratios
3.68
--
--
0.26
0.44
71.57%
-4484.33%
-4484.33%
--
7570.41%
7570.41%
$-28.83M
--
--
--
0.00
0.02
1.06
84.95
108.59%
108.59%
24.08%
80.06%
$0.23
$-0.22
$-0.22